Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100053, China
Location status: Recruiting
NCT Number: NCT05859659
Primary central nervous system (CNS) tumors, the vast majority (>90%) occurring in the brain and the remainder occurring in the meninges, spinal cord, and cranial nerves, showing an annual incidence of about 6-8 people per 100,000 population but its effects on health-care systems is out of proportion with incidence due to the substantial high rates of morbidity and mortality. Among which, glioma disease is the most common primary malignant CNS tumor, while the glioblastoma that showed the highest degree of malignancy and the worst prognosis accounts for 70-75%.
The construction goal of this project is to construct a multivariate retrospective CNS tumor database (over 50,000 cases, including 10,000 glioma) integrating clinical information, preoperative magnetic resonance imaging examination and molecular pathological results, and a prospective glioma database (3,000 cases) integrating advanced magnetic resonance sequences and postoperative follow-up. It aims to form a standardized database integrating magnetic resonance imaging, pathological results, and clinical-prognostic information.
Based on the construction of the above standardized database, the specifications for the acquisition of cranial magnetic resonance images, the image segmentation, tumor classification and labeling process, and the expert consensus on database construction and use management of CNS tumors were established. We aim to form a multimodal, large-capacity, high-quality, and rich medical imaging database that conforms to the characteristics of Chinese groups and clinical diagnosis and treatment norms. On this basis, the data are dynamically updated, in-depth mining, and the classification and grading standards of CNS tumor diseases, prognosis judgment criteria and treatment efficacy evaluation system are formulated, and providing comprehensive resources of retrospective data and prospective cohorts for large-scale reasearches, such as classification or treatment intervention predictions.
Interested in participating?
Request Info18 year–90 year
All sexes
Observational
Beijing, Beijing Municipality, 100053, China
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study does not intervene in this process.
Time frame: 2022.06-2023.12
Collecting at least 50,000 retrospective data of CNS tumors patients, including preoperative brain MRI, clinical infromations, histopathology resuluts, and molecular markers, to establish a multi-modal clinical-MRI-molecular database
Time frame: 2022.06.01-2030.12.31
Prospectively include at leaset 10,000 patients with brain space occupying lesions comfirmed by neuroimaging, recording their pre- and postoperative brain MRI, imaging diagnosis, histopathology or molecular pathology results, clinical intervention, treatment effect, and survival time.
Time frame: 2022.01-2024.12
Build a MRI-based deep-learning model to predict molecular and survival on glioma.
Time frame: 2024.12-2026.12
Developing artificial intelligence (AI) tools for brain tumors diagnosis and prediction using the retrospective MRI database with paired imaging reports and histopathological labeling, and conducting internal tests on the prospective cohort to evaluate AI model performance.
Contact information is provided by the study sponsor or research team.
Junjie Li, Master
CONTACT
Yaou Liu, Doctor
CONTACT
Yaou Liu
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07717827
Brain (Nervous System) Cancers, Brain Connectivity
Palermo, PA, Italy
View Trial DetailsNCT06804655
Astrocytoma, Brain (Nervous System) Cancers
Basel, Basel-Landschaft, Switzerland
View Trial DetailsNCT07126821
Brain (Nervous System) Cancers, Brain Arterial Disease
Changsha, Hunan, China
View Trial DetailsNCT06899516
Brain (Nervous System) Cancers, Brain Diseases
Saint-Etienne, France
View Trial Details